Federal grants to Acepre, LLC
Acepre, LLC in Columbia, South Carolina received $3.4 million in federal grants from fiscal 2021 to 2025, across 8 awards. Its largest program was Alcohol Research Programs, with $918,358. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.4 million
- Awards8
- Awarded in FY 2025$0
- Largest award$918,358
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $744,803 |
| FY 2022 | 1 | $299,628 |
| FY 2023 | 2 | $756,822 |
| FY 2024 | 4 | $1.6 million |
| FY 2025 | 0 | $0 |
Programs that fund Acepre, LLC
| Program | Awards | Amount |
|---|---|---|
| Alcohol Research Programs | 1 | $918,358 |
| Allergy and Infectious Diseases Research | 2 | $897,310 |
| Aging Research | 2 | $799,069 |
| Cancer Treatment Research | 1 | $392,803 |
| Cardiovascular Diseases Research | 1 | $299,953 |
| Research and Training in Complementary and Integrative Health | 1 | $52,000 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 8 | $3.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Developing natural compound emodin as a therapy for alcoholic cardiomyopathy - project summary: alcoholic cardiomyopathy (ACM) is the most prevalent form of ethanol-induced heart damage. Alcohol dose-dependently induces acm, characterized by progressive reduction in myocardial contractility and vent | Alcohol Research Programs | March 14, 2023 | $918,358 |
| Targeting macrophage maladaptation for bacterial sepsis treatment - summary. Sepsis results in massive loss of life and places a significant economic burden on society. There are no effective treatments available for human sepsis other than antibiotics and life support. It is increasingly clear that | Allergy and Infectious Diseases Research | June 15, 2023 | $597,310 |
| Develop a novel strategy to deliver n-acetylcysteine for ad treatment - project summary after decades of intensive research and drug development efforts, there are still no cures or substantially effective treatments for alzheimer’s disease (AD). Currently available medications, including cholineste | Aging Research | September 12, 2024 | $499,441 |
| A novel polymer-metal nanocomplex for ovarian cancer treatment - summary: ovarian cancer is the leading cause of death from gynecologic malignancy. Most women are diagnosed with metastatic ovarian cancer, and the 5-YEAR survival rate for this late stage disease is less than 28%. The mainstay of trea | Cancer Treatment Research | December 8, 2020 | $392,803 |
| Use novel natural compound sparstolonin b to treat bacterial sepsis - summary: according to the most recent CDC report, the incidence of sepsis in the united states is over 1.7 million each year, resulting in about 270,000 deaths and over $20 billion in healthcare costs. Sepsis results from infectio | Allergy and Infectious Diseases Research | February 5, 2021 | $300,000 |
| Develop natural compound emodin as a novel therapy for calcific aortic valve disease - summary: calcific aortic valve disease (CAVD) is a progressive heart disease ranging from aortic valve sclerosis to aortic valve stenosis, characterized by severe calcification with impaired leaflet function. Cavd | Cardiovascular Diseases Research | September 16, 2024 | $299,953 |
| The development of a multifunctional nanoenzyme for ad treatment - summary. The development of alzheimer’s disease (AD) is the collective consequence of the toxicities induced by ss-amyloid (ASS) plaques, tau protein-formed neurofibrillary tangles, and malfunction of microglia due to inflammation an | Aging Research | September 23, 2022 | $299,628 |
| Development of dietary quercetin to treat muscle wasting disorders | Research and Training in Complementary and Integrative Health | May 5, 2021 | $52,000 |
Questions people ask
How much federal grant money does Acepre, LLC get?
$3.4 million in 8 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Acepre, LLC the most?
The Department of Health and Human Services, with $3.4 million in 8 awards.
What is Acepre, LLC's largest federal grant?
$918,358 under Alcohol Research Programs, with its first action in the period on March 14, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Acepre, LLC?
Its largest are Alcohol Research Programs, Allergy and Infectious Diseases Research and Aging Research.
Other grant recipients in Columbia
- Department of Health Human Services
- South Carolina Department of Education
- South Carolina Department of Transportation
- Social Services South Carolina Department
- South Carolina Department of Public Health
- South Carolina Department of Social Services
- Adjutant General South Carolina
- University of South Carolina
Largest federal grant recipients in South Carolina · Federal grants in South Carolina